The rhinoceros homed viper is distributed in a band across Africa, stretching from West Africa to western Kenya (Bucherl, Buckley, and Deulofeu, 1968) . As its name implies it is characterized by a horn on its maxilla. The venom of this snake has been studied by Kirk and Corkill (1946) who found that injected into mice the venom produced local haemorrhage, and in the animals which died punctate haemorrhages were found in the kidneys and lungs. In vitro, the venom seemed to have no effect on the whole blood clotting time, but proteolytic activity was observed when the venom was incubated with gelatin.
The present communication reports the findings of more detailed studies of the effects of the venom of the rhinoceros horned viper on the haemostatic mechanism.
PROTHROMBIN CONSUMPTION TEST
Merskey's method (1950) was used. Saline or venom in saline, 0 1 ml, was added.
THROMBOPLASTIN GENERATION TEST
To the standard test system of Biggs and Douglas (1953) was added 0-2 ml saline or 0-2 ml of venom solution in saline. The destruction of formed blood thromboplastin was measured by generating blood thromboplastin in the standard mixture for five minutes and adding 0 5 ml venom (or saline) . The decay of thromboplastic activity was then measured by transferring aliquots into substrate plasma at intervals.
ONE-STAGE 'PROTHROMBIN TIMES'
Venom (or saline), 0 1 ml, was added to the test system of Douglas (1962) .
EUGLOBULIN CLOT LYSIS TIME
This was measured by the method of Nilsson and Olow (1962) . Saline, 0 1 ml, was added to the control system and 0.1 ml venom in saline in increasing concentration was added to the test system. The results are expressed in arbitrary units of activity derived from a double logarithmic plot, 1 unit representing a lysis time of 300 minutes.
CASEINOLYTIC ASSAYS
These were carried out by the method of Remmert and Cohen (1949) as modified by Alkjaersig (1960) ; the method is described by McNicol and Douglas (1964) , 0 1 M phosphate buffer being substituted for acid and alkali. Where venom was used, 0 5 ml of a 10 mg/ml solution in saline was incorporated into the system in place of 0 5 ml of the phosphate buffer being used in the assay. Similarly, buffer was substituted for streptokinase and plasminogen in the experiments in which these reagents were omitted. Results are expressed in casein units/ml. The effect on plasmin activity was assessed using a similar protocol. Plasminogen and streptokinase were omitted and replaced by preformed human plasmin (A.B. Kabi, Stockholm, Sweden).
PLATELET AGGREGATION IN THE CHANDLER'S TUBE
This was measured by a modification of the method of Chandler (1958) as described by Cunningham, McNicol, and Douglas (1965) . PLATELET ADP REACTIVITY This was measured by the method of Born and Cross (1963) , with the addition of 0-5 ml saline to the control system and 0 5 ml venom solution to the test system. Adenosine diphosphate was added to produce a final concentration of 0-5 jug/ml.
PLATELET ADHESIVENESS
This was measured by the method of Hellem (1960 ONE-STAGE 'PROTHROMBIN' TIME In the control system to which saline had been added the clotting time was 14 seconds (Table II) .
When venom was present in a final concentration of 2,500 ug/ml floccules formed at 30 seconds, but no proper clot was formed. as compared with a control system to which saline had been added in place of venom.
Effects on plasmin
Fraction 6 inhibited plasmin activity by about 18% (Table IV) . The other fractions had a negligible effect on the activity of plasmin. Platelet A DP reactivity Fraction 1 inhibited platelet ADP reactivity (Fig. 10) . Fractions 2-5 all had a similar action, enhancing platelet ADP reactivity as illustrated in Figure 10 . Fraction 6 inhibited platelet ADP reactivity and increased the optical density of the plasma. The experiments were repeated without the addition of ADP (Fig. 11) . Fraction 1 did not markedly differ from the control. Fractions 2-5 produced aggregation of platelets in the absence of ADP. Fraction 6 produced the same results as it did in the presence of ADP, increasing the optical density of the plasma, but in a further experiment, using platelet-poor plasma instead of platelet-rich plasma, the optical density was unaltered. tests. The main effect is probably on the intrinsic thromboplastin mechanism, as much higher concentrations of venom were required in order to produce an effect on the one-stage 'prothrombin' time. It is likely that the venom is interfering with the production of thromboplastin, but destruction of thromboplastin as it is being formed could be a contributing factor. Kirk and Corkill (1946) , using the whole blood clotting time, could demonstrate no change in blood coagulation in vitro. In the current study, the venom, in the highest concentration used, prolonged the whole blood clotting time to almost three times that of a control sample to which saline had been added in place of venom. Kirk and Corkill found evidence of haemorrhage when the venom was injected into mice and the differences in the studies in vitro are likely to be due to differences in the concentrations of venom which were used. There was no evidence that the venom interfered directly with the conversion of fibrinogen to fibrin under the action of thrombin. On incubation of fibrinogen with venom the thrombin clotting time was prolonged, but this has been shown to be due to the digestion of fibrinogen by the venom, the breakdown products of fibrinogen digestion presumably interfering with normal fibrin polymerization.
The observation of Kirk and Corkill (1946) , that the venom of the rhinoceros horned viper is proteolytic, has been confirmed in the present study using caseinolytic techniques. The venom was found to activate plasminogen and, like the venoms of Echis carinata (Forbes, Turpie, McNicol, and Douglas, 1966) and Dispholidus typus (MacKay, Ferguson, Ashe, Bagshawe, Forrester, and McNicol, 1969) , enhanced the activation of plasminogen by streptokinase. In addition, the venom was found to potentiate the action of purified plasmin in caseinolytic assays. When incorporated into a euglobulin clot lysis system, increased activity was only slight and occurred at an intermediate concentration, while in high concentrations inhibition was observed. This effect could possibly be explained in the presence of fractions with opposing actions, being diluted out at different rates.
Crude venom was also shown to interfere significantly with platelet function. High concentrations of venom delayed platelet aggregation in the Chandler's tube system and inhibited platelet ADP reactivity. Lower concentrations had variable effects. In the absence of ADP it was found that intermediate concentrations of venom could induce platelet aggregation in the Born system. The venom also had the property of increasing platelet adhesiveness in whole blood and plateletrich plasma.
Fractionation of the venom yielded six fractions for further study. One fraction was shown to possess marked anticoagulant activity; the other five fractions shortened the plasma recalcification time. The anticoagulant fraction was the only one to show antiplasmin action, the other five fractions having no effect on plasmin activity. It must be assumed that crude venom possesses a labile factor, which enhances plasmin activity and that this activity has been lost in the process of fractionation. The fractions also had striking effects on platelets, and the variable effects of the crude venom can possibly be explained on the presence of fractions with opposing actions. Four fractions enhanced platelet ADP reactivity and produced platelet aggregation in the absence of ADP. One fraction had no action on plateletrich plasma in the absence of ADP but reduced platelet ADP reactivity. The sixth fraction, which was anticoagulant and inhibited plasmin, also inhibited the action of ADP. This fraction was capable of increasing the optical density of platelet-rich plasma in the presence or absence of ADP. Light microscopy failed to show any morphological change in the platelets. That this effect was due to an action on the platelets was proven by the failure of the fraction to alter the optical density of platelet-poor plasma.
In view of the importance of platelets in thrombus formation and the current interest in substances which modify platelet behaviour, it is considered that this fraction is worthy of further study.
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